Litigation Details for ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD. (D.N.J. 2019)
✉ Email this page to a colleague
ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-08-08 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-12-11 |
| Cause | 28:1338 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 7,758,891; 7,820,788; 7,923,536; 8,034,375; 8,138,229; 8,268,348; 8,314,156; 8,853,260; 9,101,543; 9,393,318; 9,511,046; 9,597,409 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-08-08 | 1 | Complaint | States Patent Nos. 7,758,891 (“’891 patent”), 7,820,788 (“’788 patent”), 7,923,536 (“’536 patent”), 8,…(“’375 patent”), 8,138,229 (“’229 patent”), 8,268,348 (“’348 patent”), 8,314,156 (“’156 patent”), 8,853,260…(“’260 patent”), 9,101,543 (“’543 patent”), 9,393,318 (“’318 patent”), 9,511,046 (“’046 patent”), and… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…and 9,597,409 (“’409 patent”), all owned by Abraxis (collectively, the “patents- in-suit”). | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
